In a groundbreaking initiative, the National Institutes of Health (NIH) is spearheading a workshop titled “Artificial Intelligence in Precision Medicine for Diabetes and Other Chronic Diseases.” This event is set to explore the transformative potential of artificial intelligence (AI) and machine learning (ML) in advancing precision medicine, particularly for diabetes and chronic diseases.

The workshop seeks to unite biomedical researchers and AI/ML experts to tackle pressing challenges, identify crosscutting gaps, and seize opportunities in leveraging AI/ML technologies. The focus is on enhancing biomarker development, drug discovery, and diagnostics, ultimately paving the way for personalized healthcare solutions. Recent strides in AI/ML, including generative AI and Large Language Models, are poised to revolutionize biomedicine.

Organizing Committee
The event is organized by a distinguished committee, featuring external co-chairs such as Marcela Brissova from Vanderbilt University, Jeffrey Grethe from the University of California, San Diego, and Wei Wang from the University of California, Los Angeles. They are joined by notable members from the NIH, including Eric Brunskill, Ph.D., and Debbie Gipson, M.D., M.S.

Pre-workshop Speaker Series
A pre-workshop speaker series has been designed to stimulate discussions on AI’s intersection with biomedicine. The series is divided into two parts:

  1. The Bio-Behavioral Dimensions of Diabetes Heterogeneity: Featuring Dr. Yao Qin from the University of California, Santa Barbara, discussing “Data-driven Machine Learning and Closed-loop Diabetes Care,” and Dr. Ashu Sabharwal from Rice University on “Bio-behavioral Pathways in Diabetes.”
  2. Advances in AI and Applications in Biomedicine: Featuring Dr. James Zou from Stanford University, focusing on “AI Agents in Biomedicine,” and Dr. Eran Halperin from the University of California, Los Angeles, discussing “AI Challenges and Opportunities across Data Modalities in Medicine.”
Event Details
The workshop is a hybrid event, allowing both in-person and virtual participation. It will be held at the Neuroscience Center Building in Rockville, MD. Although registration closed on October 25, 2024, the event promises to be a pivotal moment in the integration of AI/ML in precision medicine.

For more information, interested parties can access the original article and additional resources such as the Pre-Workshop Webinar 1 Flyer and Pre-Workshop Webinar 2 Flyer.

Contact Information

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Precision Medicine Market: A Tailored Approach Revolutionizing Healthcare

With increasing governmental and private investments, the demand for precision medicine is expected to rise steadily. The commitment to addressing chronic conditions, coupled with strategic industry collaborations and advanced diagnostic tools, will sustain market growth.

U.S. Wearable Medical Devices Market: Growth Trends and Future Prospects

The U.S. wearable medical devices market, currently valued at an estimated $11.45 billion in 2023, is set to experience an astronomical rise to approximately $112.67 billion by 2033.

By |December 3, 2024|Categories: Article, Healthcare, Technology|Tags: |0 Comments

The Future of Real Estate Market: What Lies Ahead?

The real estate market is on the brink of transformation, captivating the attention of buyers, sellers, investors, and industry professionals. As we look toward the end of 2024, experts predict a shift in the landscape, particularly with home prices expected to decline due to increased inventory levels.

By |December 3, 2024|Categories: Article, Market Trends, Real Estate|Tags: , |0 Comments

Bridging the Healthcare Gap in Rural Areas with Telehealth

According to the World Health Organization (WHO), nearly two billion people in rural and remote areas worldwide lack access to essential healthcare solutions. This staggering statistic highlights a critical issue: the digital divide that limits telehealth services, primarily due to inadequate broadband access.

By |December 2, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Navigating Ethical Challenges: AI in Healthcare

As AI becomes a staple in medical practice, it carries the risk of reinforcing existing biases entrenched in historical data. These biases can lead to skewed outcomes, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic groups.

By |December 2, 2024|Categories: Article, Ethics, Healthcare|Tags: , |0 Comments

New SCLC Biomarkers Enable Advances in Precision Medicine Approaches

A groundbreaking study published in Volume 15 of Oncotarget on October 11, 2024, titled 'Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC' showcases pivotal advancements in the fight against small cell lung cancer (SCLC).

By |December 2, 2024|Categories: Article, Cancer Treatment, Medical Research|Tags: , |0 Comments